Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial: Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome.

van den Berg VJ, Umans VA, Stam F, de Mulder M, Akkerhuis KM, Cornel JH, Kardys I, Boersma E.

Circulation. 2016 Sep 27;134(13):984-6. doi: 10.1161/CIRCULATIONAHA.116.023480. No abstract available.

PMID:
27672199
2.

A curly case: dissecting giant arteriovenous anomaly - left main coronary artery shunting to superior vena cava.

de Mulder M, Hendriksz TR, de Jong PL, IJsselmuiden AJ.

EuroIntervention. 2015 Oct;11(6):e1. doi: 10.4244/EIJV11I6A132. No abstract available.

3.

Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses.

Rojas Sánchez P, de Mulder M, Fernandez-Cooke E, Prieto L, Rojo P, Jiménez de Ory S, José Mellado M, Navarro M, Tomas Ramos J, Holguín Á; Madrid Cohort of HIV-Infected Children and Adolescents Integrated in the Paediatric Branch of the Spanish National AIDS Network (CoRISPe)..

Clin Microbiol Infect. 2015 Jun;21(6):605.e1-9. doi: 10.1016/j.cmi.2015.02.003.

4.

Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cells.

Michaud HA, SenGupta D, de Mulder M, Deeks SG, Martin JN, Kobie JJ, Sacha JB, Nixon DF.

J Immunol. 2014 Aug 15;193(4):1544-8. doi: 10.4049/jimmunol.1302108.

5.

Intensive glucose control for acute myocardial infarction--reply.

de Mulder M, Umans VA, Boersma E.

JAMA Intern Med. 2014 May;174(5):826-7. doi: 10.1001/jamainternmed.2014.343. No abstract available.

PMID:
24799015
6.

Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.

Michaud HA, de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF.

Retrovirology. 2014 Jan 28;11:10. doi: 10.1186/1742-4690-11-10.

7.

HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA.

de Mulder M, York VA, Wiznia AA, Michaud HA, Nixon DF, Holguin A, Rosenberg MG.

HIV Med. 2014 Mar;15(3):135-43. doi: 10.1111/hiv.12089.

8.

Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial.

de Mulder M, Umans VA, Cornel JH, van der Zant FM, Stam F, Oemrawsingh RM, Akkerhuis KM, Boersma E.

JAMA Intern Med. 2013 Nov 11;173(20):1896-904. doi: 10.1001/jamainternmed.2013.10074.

PMID:
24018647
9.

Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in Spain.

Yebra G, de Mulder M, Holguín Á.

PLoS One. 2013 May 22;8(5):e64293. doi: 10.1371/journal.pone.0064293.

10.

High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.

de Mulder M, Yebra G, Navas A, de José MI, Gurbindo MD, González-Tomé MI, Mellado MJ, Saavedra-Lozano J, Muñoz-Fernández MÁ, de Ory SJ, Ramos JT, Holguín A; Madrid Cohort of HIV-Infected Children..

PLoS One. 2012;7(12):e52155. doi: 10.1371/journal.pone.0052155.

11.

High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission.

Briz V, García D, Méndez-Lagares G, Ruiz-Mateos E, de Mulder M, Moreno-Pérez D, Navarro ML, León-Leal JA, de José MI, Ramos JT, Mellado MJ, González-Tomé MI, Leal M, Muñoz-Fernández MA.

Pediatr Infect Dis J. 2012 Oct;31(10):1048-52.

PMID:
22828644
12.

Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.

de Mulder M, Yebra G, Navas A, Martin L, de Jose MI, Navarro ML, de Ory SJ, Gonzalez-Granado I, Mellado MJ, Ramos JT, Holguin A.

Pediatr Infect Dis J. 2012 Nov;31(11):e213-21. doi: 10.1097/INF.0b013e3182678c7c.

PMID:
22785049
13.

Basal insulin and cardiovascular and other outcomes in dysglycemia.

ORIGIN Trial Investigators., Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858.

14.

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

ORIGIN Trial Investigators., Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):309-18. doi: 10.1056/NEJMoa1203859.

15.

[Dried blood spots for monitoring HIV infection in Public Health Programs in developing countries].

De Mulder M, Holguín A.

Enferm Infecc Microbiol Clin. 2013 Feb;31(2):100-7. doi: 10.1016/j.eimc.2012.03.008. Review. Spanish.

PMID:
22560588
16.

Admission glucose does not improve GRACE score at 6 months and 5 years after myocardial infarction.

de Mulder M, van der Ploeg T, de Waard GA, Boersma E, Umans VA.

Cardiology. 2011;120(4):227-34. doi: 10.1159/000335715.

PMID:
22343543
17.

Long-term outcomes of isolated aortic valve replacement and concomitant AVR and coronary artery bypass grafting.

de Waard GA, Jansen EK, de Mulder M, Vonk AB, Umans VA.

Neth Heart J. 2012 Mar;20(3):110-7. doi: 10.1007/s12471-011-0238-6.

18.

Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses.

Yebra G, de Mulder M, Martín L, Rodríguez C, Labarga P, Viciana I, Berenguer J, Alemán MR, Pineda JA, García F, Holguín A; Cohort of the Spanish AIDS Research Network (CoRIS)..

J Clin Microbiol. 2012 Feb;50(2):407-13. doi: 10.1128/JCM.05798-11.

19.

Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population.

Yebra G, de Mulder M, Pérez-Elías MJ, Pérez-Molina JA, Galán JC, Llenas-García J, Moreno S, Holguín Á.

PLoS One. 2011;6(10):e26757. doi: 10.1371/journal.pone.0026757.

20.

Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.

de Mulder M, Yebra G, Martín L, Prieto L, Mellado MJ, Rojo P, Muñoz-Fernández MÁ, Jiménez de Ory S, Ramos JT, Holguín A; Madrid cohort of HIV-infected children..

J Antimicrob Chemother. 2011 Oct;66(10):2362-71. doi: 10.1093/jac/dkr305.

PMID:
21810838

Supplemental Content

Loading ...
Support Center